First tricyclic oximino derivatives as 5-HT3 ligands.
暂无分享,去创建一个
P Delagrange | P. Renard | B. Pfeiffer | S. Rault | P. Delagrange | F. Dauphin | R. Bureau | S Rault | P Renard | B Pfeiffer | R Bureau | J. Lancelot | I Baglin | C Daveu | J C Lancelot | F Dauphin | C. Daveu | I. Baglin
[1] P Delagrange,et al. Novel selective and partial agonists of 5-HT3 receptors. Part 1. Synthesis and biological evaluation of piperazinopyrrolothienopyrazines. , 1996, Journal of medicinal chemistry.
[2] Ronan Bureau,et al. Conformational Analysis and 3D QSAR Study on Novel Partial Agonists of 5‐HT3 Receptors , 1996 .
[3] M. Rapport,et al. Serum vasoconstrictor, serotonin; isolation and characterization. , 1948, The Journal of biological chemistry.
[4] Andrew Smellie,et al. Poling: Promoting conformational variation , 1995, J. Comput. Chem..
[5] P Delagrange,et al. Novel and selective partial agonists of 5-HT3 receptors. 2. Synthesis and biological evaluation of piperazinopyridopyrrolopyrazines, piperazinopyrroloquinoxalines, and piperazinopyridopyrroloquinoxalines. , 1997, Journal of medicinal chemistry.
[6] D. Hoyer,et al. Identification of serotonin 5-HT3 recognition sites by radioligand binding in NG108-15 neuroblastoma-glioma cells. , 1987, European journal of pharmacology.
[7] Gavin Kilpatrick,et al. 5‐HT3 receptors , 1990, Annals of the New York Academy of Sciences.
[8] M. Hamon,et al. Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure. , 1997, Journal of medicinal chemistry.
[9] S. Rault,et al. A convenient synthesis of new aminopyrroloindoles via an imminium salt , 1985 .
[10] T. Langer,et al. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives. , 1998, Journal of medicinal chemistry.
[11] Gavin Kilpatrick,et al. The pharmacological characterization of 5‐HT3 receptors in three isolated preparations derived from guinea‐pig tissues , 1990, British journal of pharmacology.
[12] E. Novellino,et al. Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies. , 1999, Journal of medicinal chemistry.
[13] Trevor Sharp,et al. A review of central 5-HT receptors and their function , 1999, Neuropharmacology.
[14] M. Hamon,et al. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors. , 1999, Journal of medicinal chemistry.